Dysregulated expression of FOXM1 is implicated not only in cancers but also in several aging-related diseases,65 e.g., pulmonary fibrosis, a disease with upregulated FOXM1,46 is mitigated by chemical or genetic inhibition of PGAM1-Chk1 binding. Here, CHEK1 is linked to pulmonary fibrosis.